EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. B.R. CELLI AND P.J. BARNES. EUR RESPIR J 2007; 29: 1224 1238.


Source: Eur Respir J 2007; 30: 401
Journal Issue: August
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. B.R. CELLI AND P.J. BARNES. EUR RESPIR J 2007; 29: 1224 1238.. Eur Respir J 2007; 30: 401

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
INVASIVE PULMONARY ASPERGILLOSIS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. P. BULPA, A. DIVE AND Y. SIBILLE. EUR RESPIR J 2007; 30: 782 800.
Source: Eur Respir J 2007; 30: 1236
Year: 2007


"BECLOMETHASONE/FORMOTEROL VERSUS BUDESONIDE/FORMOTEROL COMBINATION THERAPY IN ASTHMA". A. PAPI, P.L. PAGGIARO, G. NICOLINI, A.M. VIGNOLA AND L.M. FABBRI ON BEHALF OF THE INHALED COMBINATION ASTHMA TREATMENT VERSUS SYMBICORT (ICAT SY) STUDY GROUP. EUR RESPIR J 2007; 29: 682-689.
Source: Eur Respir J 2008; 32: 822
Year: 2008


"TACROLIMUS FOR ANTISYNTHETASE SYNDROME WITH INTERSTITIAL LUNG DISEASE?" [REPLY LETTER]. L.P. NICOD. EUR RESPIR J 2008; 32: 245-246.
Source: Eur Respir J 2008; 32: 822
Year: 2008


ACTIVATION OF E-PROSTANOID4 AND E-PROSTANOID2 RECEPTORS INHIBITS TNF-α RELEASE FROM HUMAN ALVEOLAR MACROPHAGES. M.J. RATCLIFFE, A. WALDING, P.A. SHELTON, A. FLAHERTY AND I.G. DOUGALL. EUR RESPIR J 2007; 29: 986 994.
Source: Eur Respir J 2007; 30: 1236
Year: 2007


"FREQUENCY AND CLINICAL CHARACTERISTICS OF RAPID-ONSET FATAL AND NEAR-FATAL ASTHMA". V. PLAZA, J. SERRANO, C. PICADO, J. SANCHIS, ON BEHALF OF THE HIGH RISK ASTHMA RESEARCH GROUP. EUR RESPIR J 2002; 19: 846-852.
Source: Eur Respir J 2009; 33: 1240
Year: 2009


"LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN IDIOPATHIC PULMONARY FIBROSIS: A TISSUE DOPPLER ECG STUDY". C.E. PAPADOPOULOS, G. PITSIOU, T.D. KARAMITSOS, H.I. KARVOUNIS, T. KONTAKIOTIS, G. GIANNAKOULAS, G.K. EFTHIMIADIS, P. ARGYROPOULOU, G.E. PARHARIDIS AND D. BOUROS. EUR RESPIR J 2008; 31: 701-706.
Source: Eur Respir J 2008; 32: 534
Year: 2008


SARCOIDOSIS AND MIF GENE POLYMORPHISM: A CASE CONTROL STUDY IN AN IRISH POPULATION. B.J. PLANT, S. GHANI, M.J. O'MAHONY, L. MORGAN, C.M. O'CONNOR, K. MORGAN, J.A. BAUGH AND S.C. DONNELLY. EUR RESPIR J 2007; 29: 325 329.
Source: Eur Respir J 2007; 30: 401
Year: 2007


RELATIONSHIP BETWEEN RESPIRATORY SYMPTOMS AND MEDICAL TREATMENT IN EXACERBATIONS OF COPD. EUR RESPIR J 2005; 26: 406-413.
Source: Eur Respir J 2006; 27: 440
Year: 2006


"PROGRESSION OF SNORING AND OBSTRUCTIVE SLEEP APNOEA: THE ROLE OF INCREASING WEIGHT AND TIME". G. BERGER, R. BERGER AND A. OKSENBERG. EUR RESPIR J 2009; 33: 338-345.
Source: Eur Respir J 2009; 33: 947
Year: 2009


"LUNG VOLUME MEASUREMENTS" [REPLY LETTER]. M. CAZZOLA, V. BRUSASCO AND F.J. MARTINEZ. EUR RESPIR J 2008; 32: 528.
Source: Eur Respir J 2008; 32: 822
Year: 2008


EFFECTS OF CICLESONIDE AND FLUTICASONE ON CORTISOL SECRETION IN PATIENTS WITH PERSISTENT ASTHMA. E. DEROM, R. LOUIS, C. TIESLER, R. ENGELSTATTER, J-M. KAUFMAN AND G.F. JOOS. EUR RESPIR J 2009; 33: 1277-1286.
Source: Eur Respir J 2009; 34: 783
Year: 2009


"AIRWAY DENDRITIC CELL PHENOTYPES IN INFLAMMATORY DISEASES OF THE HUMAN LUNG". M. LOMMATZSCH, K. BRATKE, A. BIER, P. JULIUS, M. KUEPPER, W. LUTTMANN AND J.C. VIRCHOW. SO - Eur Respir J 2007; 30: 878 886.
Source: Eur Respir J 2008; 31: 226
Year: 2008


ANTIBIOTICS FOR CHRONIC BRONCHITIS: A META-ANALYSIS THAT SPEAKS ONLY FOUR LANGUAGES. M. MIRAVITLLES, B. CELLI AND A. ANZUETO. EUR RESPIR J 2007; 30: 815.
Source: Eur Respir J 2007; 30: 1236
Year: 2007


"PREMATURE DISCONTINUATION OF PATIENTS: A POTENTIAL BIAS IN COPD CLINICAL TRIALS". S. KESTEN, M. PLAUTZ, C.A. PIQUETTE, M.P. HABIB AND D.E. NIEWOEHNER. SO - Eur Respir J 2007; 30: 898 906.
Source: Eur Respir J 2008; 31: 226
Year: 2008


"REDUCED MITOCHONDRIAL DENSITY IN THE VASTUS LATERALIS MUSCLE OF PATIENTS WITH COPD". H.R. GOSKER, M.K.C. HESSELINK, H. DUIMEL, K.A. WARD AND A.M.W.J. SCHOLS. EUR RESPIR J 2007; 30: 73 79.
Source: Eur Respir J 2007; 30: 817
Year: 2007


IMPACT OF SMOKE-FREE WORKPLACE LEGISLATION ON EXPOSURES AND HEALTH: POSSIBILITIES FOR PREVENTION. M.S. JAAKKOLA AND J.J.K. JAAKKOLA. EUR RESPIR J 2006; 28: 397-408.
Source: Eur Respir J 2006 Oct 01;28(4):887-888
Year: 2006


BUDESONIDE/FORMOTEROL MAINTENANCE AND RELIEVER THERAPY: AN EFFECTIVE ASTHMA TREATMENT OPTION? EUR RESPIR J 2005; 26: 819-828.
Source: Eur Respir J 2005; 26: 1191
Year: 2005


“ASSESSING THE TREATMENT EFFECT FROM MULTIPLE TRIALS IN IDIOPATHIC PULMONARY FIBROSIS.” L. RICHELDI. EUR RESPIR REV 2012; 21: 147–151.
Source: Eur Respir Rev 2012 21:263
Year: 2012


EXCLUSION OF ACTIVE MYCOBACTERIUM TUBERCULOSIS COMPLEX INFECTION WITH THE T-SPOTTM.TB ASSAY. R.M.L. VAN LEEUWEN, A.W.J. BOSSINK AND S.F.T. THIJSEN. EUR RESPIR J 2007; 29: 605-607.
Source: Eur Respir J 2007; 29: 1286
Year: 2007


"HOW MUCH IS TOO MUCH? THE TREATMENT OF MILD ASTHMA". P.M. O'BYRNE. EUR RESPIR J 2007; 30: 403 406.
Source: Eur Respir J 2007; 30: 1026
Year: 2007